ACADIA Pharmaceuticals Inc (ACAD) Ownership

18.66 ↓0.03 (-0.16%)
As of Market Close on January 26th, 2023.

Institutional Ownership

Baker Bros Advisors LP is the biggest individual institutional holder of ACADIA Pharmaceuticals Inc (ACAD), owning a total of 41.9 million shares. Combined, the top 22 institutional holders of ACAD own 77.30% of the company with a total of 125.2 million shares.

In the latest ownership report on September 30th 2022, the top 22 institutional holders increased their combined ownership of ACAD by 2.3 million shares. 11 institutions bought 3,918,550 total additional shares and increased their ownership by an average of 27.18%. However 6 institutions sold 1,576,603 total shares and decreased their ownership by an average of 5.05%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of ACADIA Pharmaceuticals increased by a net total of 2,341,947 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Baker Bros Advisors LP25.890%0.000%41,923,48602022-09-30
Vanguard Group Inc7.982%4.234%12,925,641525,0482022-09-30
FMR Inc7.146%-6.677%11,571,025-827,9322022-09-30
BlackRock Inc6.159%2.380%9,973,155231,8412022-09-30
State Street Corporation4.186%2.804%6,778,871184,9212022-09-30
EcoR1 Capital, LLC3.700%0.000%5,991,47902022-09-30
T. Rowe Price Associates, Inc.3.021%4.211%4,891,348197,6332022-09-30
D. E. Shaw & Co LP2.910%0.544%4,712,18025,5152022-09-30
RTW INVESTMENTS, LLC2.267%-13.096%3,670,938-553,1712022-09-30
Morgan Stanley - Brokerage Accounts1.897%-1.569%3,071,113-48,9592022-09-30
First Trust Advisors L.P.1.803%34.479%2,919,860748,6182022-09-30
Geode Capital Management, LLC1.372%2.784%2,221,15160,1672022-09-30
JPMorgan Chase & Co1.148%-2.505%1,858,961-47,7592022-09-30
Wellington Management Company LLP1.058%124.307%1,712,787949,1962022-09-30
Palo Alto Investors, LLC1.036%0.000%1,678,19602022-09-30
Fred Alger Management, LLC0.949%-5.237%1,536,834-84,9342022-09-30
Emerald Advisers, LLC0.821%54.473%1,329,626468,8772022-09-30
Boxer Capital LLC0.781%0.000%1,263,93002022-09-30
Goldman Sachs Group Inc0.729%11.622%1,180,398122,9042022-09-30
Northern Trust Corp0.690%-1.225%1,116,939-13,8482022-09-30
Finepoint Capital LP0.686%57.103%1,111,030403,8302022-09-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Baker Bros Advisors LP25.890%0.000%41,923,48602022-09-30
Vanguard Group Inc7.982%4.234%12,925,641525,0482022-09-30
FMR Inc7.146%-6.677%11,571,025-827,9322022-09-30
BlackRock Inc6.159%2.380%9,973,155231,8412022-09-30
State Street Corporation4.186%2.804%6,778,871184,9212022-09-30
EcoR1 Capital, LLC3.700%0.000%5,991,47902022-09-30
T. Rowe Price Associates, Inc.3.021%4.211%4,891,348197,6332022-09-30
D. E. Shaw & Co LP2.910%0.544%4,712,18025,5152022-09-30
RTW INVESTMENTS, LLC2.267%-13.096%3,670,938-553,1712022-09-30
Morgan Stanley - Brokerage Accounts1.897%-1.569%3,071,113-48,9592022-09-30
First Trust Advisors L.P.1.803%34.479%2,919,860748,6182022-09-30
Geode Capital Management, LLC1.372%2.784%2,221,15160,1672022-09-30
JPMorgan Chase & Co1.148%-2.505%1,858,961-47,7592022-09-30
Deep Track Capital, LP1.070%0.000%1,733,1301,733,1302022-06-30
Wellington Management Company LLP1.058%124.307%1,712,787949,1962022-09-30
Palo Alto Investors, LLC1.036%0.000%1,678,19602022-09-30
Fred Alger Management, LLC0.949%-5.237%1,536,834-84,9342022-09-30
Emerald Advisers, LLC0.821%54.473%1,329,626468,8772022-09-30
Boxer Capital LLC0.781%0.000%1,263,93002022-09-30
Goldman Sachs Group Inc0.729%11.622%1,180,398122,9042022-09-30
Northern Trust Corp0.690%-1.225%1,116,939-13,8482022-09-30
Finepoint Capital LP0.686%57.103%1,111,030403,8302022-09-30

Mutual Fund Ownership

SPDR® S&P Biotech ETF is the biggest individual fund holder of ACADIA Pharmaceuticals Inc (ACAD), owning a total of 5.3 million shares. Combined, the top 20 mutual fund holders of ACAD own 27.04% of the company with a total of 43.8 million shares.

In the latest ownership report on December 31st 2022, the top 20 fund holders decreased their combined ownership of ACAD by 47 thousand shares. None of the mutual funds bought any additional shares. However 1 funds sold 46,920 total shares and decreased their ownership by an average of 0.87%.

Overall this is a negative sign as the number of shares owned by the top 20 mutual funds holding ACADIA Pharmaceuticals decreased by a net total of -46,920 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
SPDR® S&P Biotech ETF3.291%-0.873%5,328,749-46,9202022-12-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
SPDR® S&P Biotech ETF3.291%-0.873%5,328,749-46,9202022-12-31
Fidelity Growth Compy Commingled Pl 32.966%-8.388%4,803,005-439,7642022-11-30
Vanguard Total Stock Mkt Idx Inv2.282%0.219%3,695,0478,0592022-11-30
Vanguard Instl Ttl Stck Mkt Idx Tr2.266%2.731%3,668,84097,5462022-09-30
Fidelity® Growth Company1.996%-13.408%3,232,289-500,5072022-11-30
Vanguard Small Cap Index1.935%0.008%3,133,8872582022-11-30
First Trust NYSE Arca Biotech ETF1.705%0.000%2,761,53402022-12-29
iShares Russell 2000 ETF1.697%-0.830%2,747,989-23,0002022-12-30
Vanguard Small Cap Growth Index Inv1.126%0.267%1,823,7134,8592022-11-30
Vanguard Extended Market Index Investor1.018%0.140%1,647,7602,3102022-11-30
T. Rowe Price New Horizons0.954%4.897%1,544,45872,1052022-09-30
T. Rowe Price Health Sciences0.924%5.453%1,495,85777,3532022-09-30
iShares Biotechnology ETF0.815%-0.721%1,319,847-9,5912022-12-30
Fidelity® Growth Company K60.641%-5.494%1,037,778-60,3292022-11-30
Fidelity® Series Growth Company0.635%-8.715%1,028,571-98,2002022-11-30
JPMorgan Small Cap Growth A0.626%0.000%1,013,06602022-11-30
iShares Russell 2000 Growth ETF0.618%0.113%1,001,2081,1262022-12-30
Fidelity® Small Cap Index0.587%1.962%950,68218,2942022-10-31
Vanguard Strategic Equity Inv0.519%0.000%840,13002022-10-31
T. Rowe Price QM US Small-Cap Gr Eq0.442%0.000%715,61202022-09-30

Discussions

Please log in or register to share your thoughts.